EpirubicinCyclophosphamideTaxoidsDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticDrug Administration ScheduleBreast NeoplasmsPaclitaxelFluorouracilVincristineAntineoplastic Agents, PhytogenicTreatment OutcomeCisplatinAntineoplastic AgentsPrednisoneAntineoplastic Agents, AlkylatingChemotherapy, AdjuvantPhosphoramide MustardsDisease-Free SurvivalDose-Response Relationship, DrugMethotrexateCombined Modality TherapyLeukopeniaGranulocyte Colony-Stimulating FactorEtoposideNeutropeniaVinblastineSurvival AnalysisNeoadjuvant TherapyInfusions, IntravenousDeoxycytidineSurvival RateNeoplasm MetastasisAnthracyclinesRemission InductionLung NeoplasmsNaphthacenesMitoxantroneAlopeciaNeoplasm StagingDrug Resistance, NeoplasmRazoxaneMaximum Tolerated DoseIfosfamideImmunosuppressive AgentsDaunorubicinThiotepaDrug ResistancePulse Therapy, DrugTime FactorsCarboplatinAdenocarcinomaPrednisoloneLymphoma, Non-HodgkinDrug Therapy, CombinationBusulfanHematologic DiseasesFollow-Up StudiesDrug SynergismNauseaStomach NeoplasmsBleomycinCell SurvivalVomitingNeoplasmsNeoplasm Recurrence, LocalStomatitisProstatic NeoplasmsAntibodies, Monoclonal, Murine-DerivedLymphatic MetastasisP-GlycoproteinReceptor, erbB-2Leukemia L1210Disease ProgressionCell Line, TumorPrognosisDrug EvaluationNogalamycinMelphalanBone NeoplasmsAntibodies, Monoclonal, HumanizedMethylprednisoloneVidarabineBone Marrow TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationInjections, IntravenousAntibodies, MonoclonalEstramustineCarmustineProspective StudiesCarcinoma, Non-Small-Cell LungAstheniaBiotransformationAdministration, OralDrug Resistance, MultipleLeukemia P388Carcinoma, Small CellOvarian Neoplasms